MetLife Inc. [NYSE: MET] stock went on a downward path that fall over -1.17% on Wednesday, amounting to a one-week price decrease of less than -4.11%. The company report on October 12, 2022 that Inflation Is the Leading Catalyst for Pension Risk Transfer Activity, MetLife Poll Finds.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
95% of plan sponsors report higher inflation is impacting their decision to de-risk, according to MetLife’s 2022 Pension Risk Transfer Poll.
Nearly all defined benefit (DB) plan sponsors, 95%, say that higher inflation is impacting their decision to move forward with a pension risk transfer (PRT), including 50% saying it’s very impactful, according to MetLife’s new 2022 Pension Risk Transfer Poll, released today. The Poll found that inflation is the leading catalyst for DB plan sponsors to initiate a PRT.
Over the last 12 months, MET stock dropped by -3.40%. The one-year MetLife Inc. stock forecast points to a potential upside of 18.99. The average equity rating for MET stock is currently 1.80, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $50.94 billion, with 809.70 million shares outstanding and 670.73 million shares in the current float. Compared to the average trading volume of 4.26M shares, MET stock reached a trading volume of 4227612 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on MetLife Inc. [MET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $77.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for MetLife Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on September 22, 2022. While these analysts kept the previous recommendation, Wolfe Research raised their target price from $70 to $74. The new note on the price target was released on June 23, 2022, representing the official price target for MetLife Inc. stock. Previously, the target price had yet another raise to $77, while Citigroup analysts kept a Buy rating on MET stock.
The Average True Range (ATR) for MetLife Inc. is set at 1.64, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.75. The Price to Book ratio for the last quarter was 1.37, with the Price to Cash per share for the same quarter was set at 25.24. Price to Free Cash Flow for MET in the course of the last twelve months was 3.74.
MET Stock Performance Analysis:
MetLife Inc. [MET] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.11. With this latest performance, MET shares dropped by -5.85% in over the last four-week period, additionally sinking by -10.80% over the last 6 months – not to mention a drop of -3.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 44.20, with the RSI for the last a single of trading hit 42.74, and the three-weeks RSI is set at 45.40 for MetLife Inc. [MET]. The present Moving Average for the last 50 days of trading for this stock 64.93, while it was recorded at 63.42 for the last single week of trading, and 65.73 for the last 200 days.
Insight into MetLife Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and MetLife Inc. [MET] shares currently have an operating margin of +10.97. MetLife Inc.’s Net Margin is presently recorded at +9.41.
Return on Equity for this stock inclined to 9.23, with Return on Assets sitting at 0.84.
MET Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MetLife Inc. go to -0.43%.
MetLife Inc. [MET] Insider Position Details
There are presently around $36,552 million, or 75.00% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: BLACKROCK INC. with ownership of 62,660,874, which is approximately -10.722% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 57,074,015 shares of the stock with an approximate value of $3.57 billion in MET stocks shares; and DODGE & COX, currently with $3.57 billion in MET stock with ownership of nearly -2.495% of the company’s market capitalization.
Positions in MetLife Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 595 institutional holders increased their position in MetLife Inc. [NYSE:MET] by around 27,365,516 shares. Additionally, 510 investors decreased positions by around 43,075,689 shares, while 198 investors held positions by with 513,636,381 shares. The mentioned changes placed institutional holdings at 584,077,586 shares, according to the latest SEC report filing. MET stock had 98 new institutional investments in for a total of 3,627,998 shares, while 107 institutional investors sold positions of 5,229,912 shares during the same period.